Glaxosmithkline Pharmaceuticals Ltd
Glaxosmi. Pharma | 500660
Share Price Chart - Glaxosmithkline Pharmaceuticals Ltd
Stock Performance
Ratios
About Company
- GlaxoSmithKline Pharmaceuticals Limited was erstwhile incorporated as 'Glindia Limited' in November, 1924
- The Company' s name was changed to Glaxo (India) Limited' in 1987 and was again changed to 'GlaxoSmithKline Pharmaceuticals Limited' dated October 22, 2001
- GlaxoSmithKline Pharmaceuticals Limited is the Indian subsidiary of GSK plc, a UK-based, science-led global healthcare organisation focused on uniting science, technology and talent to get ahead of disease
- The Company is headquartered in Mumbai and it has six branch offices, one manufacturing facility at Nashik in Maharashtra, 20 contract manufacturing organisations (CMOs) with regional and sales hubs across India
- The Company is engaged interalia, in the business of manufacturing, distributing and trading in pharmaceuticals
- The Company's portfolio includes General Medicines, Vaccines and Specialty medicines that help prevent and treat disease
- Their prescription medicines range across therapeutic areas, such as Anti-Infectives, Dermatology, Gynaecology, Diabetes, Oncology, Cardiovascular Disease and Respiratory Diseases
- They also offer a range of vaccines, for the prevention of Hepatitis A, Hepatitis B, Invasive Disease caused by H, Influenza, Chickenpox, Diphtheria, Pertussis, Tetanus, Rotavirus, Cervical Cancer and Others
- They have two manufacturing units in India, located at Nashik and Thane
- Also, they have a clinical development centre in Bangalore
Ethics: Glaxosmithkline Pharmaceuticals Ltd is flagged for
Animal Cruelty
The company engages directly in some form of animal cruelty through its business.
Research Calls
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *
Top Gainers
Top Losers
Frequently Asked Questions
What is Share Price of Glaxosmithkline Pharmaceuticals Ltd?
The current share price of Glaxosmithkline Pharmaceuticals Ltd (Glaxosmi. Pharma) is ₹2459.00. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Glaxosmithkline Pharmaceuticals Ltd?
The Price-to-Earnings (P/E) ratio of Glaxosmithkline Pharmaceuticals Ltd is 2459.00. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Glaxosmithkline Pharmaceuticals Ltd?
Glaxosmithkline Pharmaceuticals Ltd has a 52-week high of ₹3254.90 and a 52-week low of ₹2088.10. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Glaxosmithkline Pharmaceuticals Ltd?
Glaxosmithkline Pharmaceuticals Ltd offers a dividend yield of 2.35%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Glaxosmithkline Pharmaceuticals Ltd?
The Earnings Per Share (EPS) of Glaxosmithkline Pharmaceuticals Ltd is ₹56.80. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Glaxosmithkline Pharmaceuticals Ltd?
Glaxosmithkline Pharmaceuticals Ltd has a Return on Equity (ROE) of 48.29%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
